We are live on ! Find out more
SNOA icon

Sonoma Pharmaceuticals

15 hedge funds and large institutions have $473K invested in Sonoma Pharmaceuticals in 2014 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 2 increasing their positions, 0 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

400% more first-time investments, than exits

New positions opened: 5 | Existing positions closed: 1

25% more funds holding

Funds holding: 1215 (+3)

46% less capital invested

Capital invested by funds: $870K → $473K (-$397K)

Holders
15
Holders Change
+3
Holders Change %
+25%
% of All Funds
0.4%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
5
Increased
2
Reduced
Closed
1
Calls
Puts
Net Calls
Net Calls Change

SNOA Hedge Fund Activity: Q4 2014 in Review

15 of the 3,750 institutional investors tracked by Wall St. Rank reported a position in Sonoma Pharmaceuticals (SNOA) for Q4 2014, worth a combined $473K — down 46% from $870K a quarter earlier.

Buyers outnumbered sellers: 5 funds opened new SNOA positions and 1 closed out — a net gain of 4 holders — while 2 added to existing stakes and 0 trimmed.

The largest buyer was B. Riley Wealth Advisors, adding an estimated $73.2K. The largest seller was Jane Street, exiting entirely with an estimated $28K sold.

  • 15 institutional investors held Sonoma Pharmaceuticals (SNOA) as of Q4 2014, up from 12 in Q3 2014.
  • Funds reported $473K of Sonoma Pharmaceuticals stock for Q4 2014, down 46% quarter-over-quarter.
  • 5 funds opened new Sonoma Pharmaceuticals positions in Q4 2014 and 1 closed out, a net change of +4 holders.
  • The largest Sonoma Pharmaceuticals buyer in Q4 2014 was B. Riley Wealth Advisors, an estimated $73.2K added.
  • The largest Sonoma Pharmaceuticals seller in Q4 2014 was Jane Street, an estimated $28K sold.

Based on aggregated 13F filings for Q4 2014.